Nanocarriers as an emerging platform for cancer therapy.

by Dan Peer, Jeffrey M Karp, Seungpyo Hong, Omid C Farokhzad, Rimona Margalit, Robert Langer
Nature nanotechnology ()
Get full text at journal

Abstract

Nanotechnology has the potential to revolutionize cancer diagnosis and therapy. Advances in protein engineering and materials science have contributed to novel nanoscale targeting approaches that may bring new hope to cancer patients. Several therapeutic nanocarriers have been approved for clinical use. However, to date, there are only a few clinically approved nanocarriers that incorporate molecules to selectively bind and target cancer cells. This review examines some of the approved formulations and discusses the challenges in translating basic research to the clinic. We detail the arsenal of nanocarriers and molecules available for selective tumour targeting, and emphasize the challenges in cancer treatment.

Cite this document (BETA)

Authors on Mendeley

Readership Statistics

1356 Readers on Mendeley
by Discipline
 
31% Biological Sciences
 
23% Chemistry
 
13% Engineering
by Academic Status
 
32% Ph.D. Student
 
18% Student (Master)
 
8% Student (Bachelor)
by Country
 
3% United States
 
1% India
 
1% Canada

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in